Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more

White Paper: Market Access Landscape for Health Apps in Europe

Get insights from MTRC White Papers to explore practical strategies for navigating digital health reimbursement in Europe and discover how health app developers build effective strategies for market entry and scale 

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

EU HTA Publication Digest: Classification grid and evidence matrix for evaluating digital medical devices under the European Union landscape

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. 

In a recent publication, Boers et al. introduced the Common European Classification Grid (CEUGrid-DMD) and an Evidence Matrix to harmonize the evaluation of digital medical devices (DMDs) across the EU. The framework was developed through comparative mapping of national schemes, a survey of HTA bodies in nine countries, and expert workshops. It establishes five functional categories of DMDs and links them to four taxonomy groups with corresponding evidence domains. These tools aim to reduce heterogeneity in national assessments and enable joint EU-level evaluations under the new HTA Regulation.

Access the full-text article here.